Antibodies against oxidized LDL - Theory and clinical use

Physiological Research

Volumn 50, Issue 2, 2001, Pages 131-141

  Steinerova A ^a   Racek, J ^a   Stozicky F ^a   Zima, T ^b   Fialova L ^b   Lapin, A ^c  

^a CHARLES UNIVERSITY   (Czech Republic)

^b CHARLES UNIVERSITY   (Czech Republic)

^c MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

Atherosclerosis; Autoantibodies; IgoxLDL; Low density lipoprotein; Oxidative stress

Indexed keywords

4 HYDROXYNONENAL; ADVANCED GLYCATION END PRODUCT; ALPHA TOCOPHEROL; APOLIPOPROTEIN B100; ASCORBIC ACID; BETA2 GLYCOPROTEIN ANTIBODY; IMMUNOGLOBULIN G ANTIBODY; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE; PHOSPHOLIPID ANTIBODY; PROTEIN ANTIBODY; PROTEIN IGOXLDL; UNCLASSIFIED DRUG;

ANTIBODY PRODUCTION; ANTIBODY TITER; ATHEROGENESIS; GLYCATION; HUMAN; HUMAN CELL; LIPID PEROXIDATION; LIPOPROTEIN METABOLISM; OXIDATION; OXIDATIVE STRESS; PATHOPHYSIOLOGY; PROTEIN MODIFICATION; SHORT SURVEY;

ARTERIOSCLEROSIS; AUTOANTIBODIES; HUMANS; LIPOPROTEINS, LDL; OXIDATIVE STRESS;

EID: 0035006460     PISSN: 08628408     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (67)

1. New data on pathology and etiology of arteriosclerosis (atherosclerosis)
2. Über experimentalle Cholestrinsteatose und ihre Bedeutung für die Entstehung einiger pathologischer Prozesse
3. L'hyperlipidémie par autoanticorps anti-beta-lipoprotéine. Une nouvelle entité pathologique
4. L'autoanticorps antilipoprotéine (anti Pg) du gamma-A-myélome avec hyperlipidémie: Méthode d'isolement et de purification á partir des complexes circulants
5. Immunglobulin-bound lipoproteins (Ig-Lp) as markers of familial hypercholesterolemia, xanthomatosis and atherosclerosis
6. Antigenic epitopes generated during LDL oxidation and the detection of specific autoantibodies
7. The role of oxidized lipoproteins in atherogenesis
8. Post-traumatic differences in the titer of autoantibodies against oxidized low-density lipoproteins (oLDL) in the sera of patients with bone fractures and traumatic brain injury
9. Superoxide anion participation in human monocyte-mediated oxidation of low-density lipoprotein and conversion of low-density lipoprotein to a cytotoxin
10. Immunologic aspects of heart disease
11. Estimation of peroxidative damage. A critical review
12. Mechanistic and genetic aspects of susceptibility of LDL to oxidation
13. Chemistry and pathophysiology of oxidation of LDL
14. Biochemical, structural, and functional properties of oxidized low-density lipoprotein
15. Role of natural antioxidants in inhibiting Cu-mediated oxidation of LDL
16. Endogenous antioxidants and lipoprotein oxidation
17. Inhibition of LDL oxidation by antioxidants
18. Comparison of antibodies to oxidized low density lipoprotein IgG, anti-(-2-glycoprotein 1 IgG and anticardiolipin antibodies IgG in patients with renal diseases
19. Oxidized LDL and lipoprotein(a) stimulate renin release of juxtaglomerular cells
20. Low-density lipoprotein is saturable by pro-oxidant copper
21. Immunologic reactions to tissue antigens in patients with different stages of cerebral atherosclerosis
22. Low-density lipoprotein metabolism by human macrophages activated with low-density lipoprotein immune complexes. A possible mechanism of foam cell formation
23. Autoantibodies against malondialdehyde-modified LDL are elevated in subjects with an LDL subclass pattern B
24. Cigarette smoking potentiates endothelial dysfunction of forearm resistance vessels in patients with hypercholesterolemia. Role of oxidized LDL
25. Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein
26. Detection of new epitopes formed upon oxidation of low-density lipoprotein, lipoprotein(a) and very low-density lipoprotein: Use of an antiserum against 4-hydroxynonenal modified low-density lipoprotein
27. Die Rolle der Apolipoproteine für den Stoffwechsel
28. Autoantibodies against low-density lipoprotein and atherogenic potential of blood
29. 2+ oxidized low-density lipoprotien (LDL) immunoglobulin G (IgG) antibodies in transplantation patients
30. Role of immunological factors in the pathogenesis of atherosclerosis
31. Antibodies against oxidized LDL (oLAb) in Viennese working population
32. Protection from oxidized LDL-induced leukocyte adhesion to microvascular and macrovascular endothelium in vivo by vitamin C but not by vitamin E
33. An unusual serum lipoprotein-globulin complex in a patient with hyperlipemia
34. Atherosclerosis and autoimmunity
35. Oxidized low-density lipoprotein is resistant to cathepsins and accumulates within macrophages
36. Oxidized low-density lipoprotein induces the production of superoxide by neutrophils
37. Monoclonal anticardiolipin autoantibodies established from the (New Zealand white x BXSB) F1 mouse model of antiphospholipid syndrome cross-react with oxidized low-density lipopoprotein
38. Enhanced metabolism of LDL aggregates mediated by specific human monocyte IgH Fc receptors
39. Auto-antibodies against oxidized LDL as a marker for coronary artery disease in patients with familiar hypercholesterolaemia
40. Role of oxidized low density lipoprotein in atherogenesis
41. New specific markers of lipoperoxidation - Isoprostanes
42. Antibodies against lipoproteins in man. Occurrence and significance
43. Clinical significance of lipoprotein size and risk for coronary atherosclerosis
44. The pathogenesis of atherosclerosis - An update
45. Autoantibody against oxidized LDL and progression of carotid atherosclerosis
46. Antibodies against oxidized low-density lipoprotein in juvenile chronic arthritis
47. Transient reduction of autoantibodies against oxidized LDL in patients with acute myocardial infarction
48. Macrophages, macrophage foam cells, and eccentric intimal thickening in the coronary arteries of young children
49. Recognition of oxidized low-density lipoprotein by the scavenger receptor of macrophages results from derivatization of apolipoprotein B by products of fatty acid peroxidation
50. Changes in superoxide dismutase activity and plasma antioxidant capacity of hyperlipidemic patients treated with either fenofibrate and alpha-tocopherol or fenofibrate only
51. Autoantibodies against oxidized LDL in the first phase of life
52. Lipid peroxidation and superoxide dismutase activity in umbilical and maternal blood
53. The effect of clofibrate and pyridinol carbamate on the circulating immune complexes and cellular immune response in experimental atherosclerosis
54. Antibodies to oxidized low density lipoprotein
55. Quantitative determination of oLab titers in various animal species
56. Anticardiolipin antibodies and risk of myocardial infarction in a prospective cohort of middle-aged men
57. Monitoring of oxidative stress markers in a patient with acute myocardial infarction
58. Antibodies as specific probes to investigate lipid peroxidation
59. Probleme der Bestimmung oxidierter Lipoproteine in vitro und in vivo
60. The oxidation hypothesis of atherosclerosis
61. Macrophages and oxidized low-density lipoproteins in the pathogenesis of atherosclerosis
62. An immunological marker of low-density lipoprotein oxidation
63. Changes of antiphospholipid antibodies and IgG oxidized low-density lipoprotein during plasma exchange in Wegener granulomatosis, myastenia gravis and anti-GBM nephritis
64. IgG antibody to oxidized low-density lipoprotein - Is it a marker of atherogenesis in patients with renal diseases?
65. Stanovení oxidovaného lipoproteinu nízké hustoty spektrofotometricky